{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:42:48Z","timestamp":1791420168748,"version":"4.3.3"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":1676,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1074\/jbc.m115.689018","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T04:59:03Z","timestamp":1450414743000},"page":"2696-2711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages"],"prefix":"10.1016","volume":"291","author":[{"given":"Bizhan","family":"Romani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima Shaykh","family":"Baygloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Hamidi-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Aghasadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Allahbakhshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M115.689018_bib1","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/JVI.73.3.1964-1973.1999","article-title":"Nef-induced CD4 and major histocompatibility complex class I (MHC-I) downregulation are governed by distinct determinants: N-terminal \u03b1-helix and proline repeat of nef selectively regulate MHC-I trafficking","volume":"73","author":"Mangasarian","year":"1999","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M115.689018_bib2","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1128\/JVI.79.15.9579-9587.2005","article-title":"Regulation of APOBEC3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB\/C ubiquitin ligase","volume":"79","author":"Liu","year":"2005","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M115.689018_bib3","doi-asserted-by":"crossref","first-page":"e1003895","DOI":"10.1371\/journal.ppat.1003895","article-title":"Preservation of thetherin and CD4 counteractivities in circulating Vpu alleles despite extensive sequence variation whithin HIV-1 infected individuals","volume":"10","author":"Pickering","year":"2014","journal-title":"Plos. Pathog"},{"key":"10.1074\/jbc.M115.689018_bib4","doi-asserted-by":"crossref","first-page":"37333","DOI":"10.1074\/jbc.M110.133181","article-title":"HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-RING E3 ubiquitin ligase for proteasome-dependent degradation","volume":"285","author":"Ahn","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.689018_bib5","doi-asserted-by":"crossref","first-page":"11778","DOI":"10.1073\/pnas.0702102104","article-title":"Lentiviral Vpr usurps Cul4\u2013DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle","volume":"104","author":"Hrecka","year":"2007","journal-title":"Pro. Nat. Aca. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.689018_bib6","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1099\/vir.0.011726-0","article-title":"Human immunodeficiency virus type 1 Vpr: functions and molecular interactions","volume":"90","author":"Romani","year":"2009","journal-title":"J. Gen. Virol"},{"key":"10.1074\/jbc.M115.689018_bib7","doi-asserted-by":"crossref","first-page":"10822","DOI":"10.1128\/JVI.01380-07","article-title":"DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest","volume":"81","author":"Tan","year":"2007","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M115.689018_bib8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature10195","article-title":"Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein","volume":"474","author":"Hrecka","year":"2011","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.689018_bib9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.689018_bib10","doi-asserted-by":"crossref","first-page":"17380","DOI":"10.1074\/jbc.M115.641522","article-title":"HIV-1 Vpr protein enhances proteasomal degradation of MCM10 DNA replication factor through the Cul4-DDB1[VprBP] E3 ubiquitin ligase to induce G2\/M cell cycle arrest","volume":"290","author":"Romani","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.689018_bib11","doi-asserted-by":"crossref","first-page":"e30939","DOI":"10.1371\/journal.pone.0030939","article-title":"The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover","volume":"7","author":"Wen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M115.689018_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.virol.2013.06.010","article-title":"The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection","volume":"444","author":"Casey Klockow","year":"2013","journal-title":"Virology"},{"key":"10.1074\/jbc.M115.689018_bib13","doi-asserted-by":"crossref","first-page":"15474","DOI":"10.1074\/jbc.M112.416735","article-title":"HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.689018_bib14","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1093\/nar\/gks366","article-title":"CRL4-DDB1-VPRBP ubiquitin ligase mediates the stress triggered proteolysis of Mcm10","volume":"40","author":"Kaur","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/jbc.M115.689018_bib15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/MCB.06037-11","article-title":"Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail","volume":"32","author":"Kim","year":"2012","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.M115.689018_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res"},{"key":"10.1074\/jbc.M115.689018_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1074\/jbc.M115.689018_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol. Oncol"},{"key":"10.1074\/jbc.M115.689018_bib19","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M115.689018_bib20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","article-title":"Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.689018_bib21","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M115.689018_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1868-7083-4-5","article-title":"Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors","volume":"4","author":"Delcuve","year":"2012","journal-title":"Clinical Epigenetics"},{"key":"10.1074\/jbc.M115.689018_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1182\/blood-2007-04-085076","article-title":"Histone deacetylase-mediated transcriptional activation reduces proviral loads in HTLV-1-associated myelopathy\/tropical spastic paraparesis patients","volume":"110","author":"Lezin","year":"2007","journal-title":"Blood"},{"key":"10.1074\/jbc.M115.689018_bib24","doi-asserted-by":"crossref","first-page":"15443","DOI":"10.1128\/JVI.79.24.15443-15451.2005","article-title":"Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo","volume":"79","author":"Lai","year":"2005","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M115.689018_bib25","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/j.1460-2075.1996.tb00449.x","article-title":"Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation","volume":"15","author":"Van-Lint","year":"1996","journal-title":"EMBO J"},{"key":"10.1074\/jbc.M115.689018_bib26","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1002\/j.1460-2075.1993.tb05994.x","article-title":"Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation","volume":"12","author":"Verdin","year":"1993","journal-title":"EMBO J"},{"key":"10.1074\/jbc.M115.689018_bib27","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1128\/JVI.02590-09","article-title":"HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest","volume":"7","author":"Belzile","year":"2010","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M115.689018_bib28","doi-asserted-by":"crossref","first-page":"e102684","DOI":"10.1371\/journal.pone.0102684","article-title":"Selective HDAC inhibition for the disruption of latent HIV-1 infection","volume":"9","author":"Barton","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M115.689018_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(05)67098-5","article-title":"Depletion of latent HIV-1 infection in vivo: a proof-of-concept study","volume":"366","author":"Lehrman","year":"2005","journal-title":"Lancet"},{"key":"10.1074\/jbc.M115.689018_bib30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1089\/aid.2008.0294","article-title":"Activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma","volume":"25","author":"Edelstein","year":"2009","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1074\/jbc.M115.689018_bib31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00002030-200405210-00003","article-title":"Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression","volume":"18","author":"Ylisastigui","year":"2004","journal-title":"AIDS"},{"key":"10.1074\/jbc.M115.689018_bib32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.689018_bib33","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1073\/pnas.91.23.10873","article-title":"Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1","volume":"91","author":"Levy","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1074\/jbc.M115.689018_bib34","doi-asserted-by":"crossref","first-page":"61133","DOI":"10.1189\/jlb.0809547","article-title":"HIV-1 Vpr induces TLR4\/MyD88-mediated IL-6 production and reactivates viral production from latency","volume":"87","author":"Hoshino","year":"2010","journal-title":"J. Leuk. Biol"},{"key":"10.1074\/jbc.M115.689018_bib35","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1128\/jvi.69.2.1243-1252.1995","article-title":"Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency","volume":"69","author":"Levy","year":"1995","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M115.689018_bib36","doi-asserted-by":"crossref","first-page":"13307","DOI":"10.1128\/JVI.02257-13","article-title":"LINE-1 retrotransposable element DNA accumulates in HIV-1-infected cells","volume":"87","author":"Jones","year":"2013","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M115.689018_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1742-4690-10-83","article-title":"Viral protein R of human immunodeficiency virus type-1 induces retrotransposition of long interspersed element-1","volume":"10","author":"Iijima","year":"2013","journal-title":"Retrovirology"},{"key":"10.1074\/jbc.M115.689018_bib38","doi-asserted-by":"crossref","first-page":"e1000463","DOI":"10.1371\/journal.ppat.1000463","article-title":"Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication","volume":"5","author":"Sorin","year":"2009","journal-title":"PLoS Path"},{"key":"10.1074\/jbc.M115.689018_bib39","doi-asserted-by":"crossref","first-page":"28419","DOI":"10.1074\/jbc.M403875200","article-title":"Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages","volume":"279","author":"Chen","year":"2004","journal-title":"J. Biol. Chem"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820342630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820342630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M115.689018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T06:17:34Z","timestamp":1641277054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820342630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0021925820342630"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m115.689018","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M115.689018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}